IASIS PHARMA has launched a new pharmaceutical product under the brand name Αxibal (Ibandronic acid). Αxibal 150mg f.c. tabs, is indicated for the treatment and prevention of osteoporosis in post-menopausal women. The simple dosage regimen (Once monthly) improves the patient compliance in the treatment of osteoporosis.
RABEREN/ΙΑSIS PRESS RELEASE28/04/2014
ΑVALSAN PLUS PRESS RELEASE10/02/2014